247 related articles for article (PubMed ID: 9506559)
1. Low frequency of alpha-synuclein mutations in familial Parkinson's disease.
Farrer M; Wavrant-De Vrieze F; Crook R; Boles L; Perez-Tur J; Hardy J; Johnson WG; Steele J; Maraganore D; Gwinn K; Lynch T
Ann Neurol; 1998 Mar; 43(3):394-7. PubMed ID: 9506559
[TBL] [Abstract][Full Text] [Related]
2. Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease.
Langston JW; Sastry S; Chan P; Forno LS; Bolin LM; Di Monte DA
Exp Neurol; 1998 Dec; 154(2):684-90. PubMed ID: 9878203
[TBL] [Abstract][Full Text] [Related]
3. Alpha-synuclein missense and multiplication mutations in autosomal dominant Parkinson's disease.
Hope AD; Myhre R; Kachergus J; Lincoln S; Bisceglio G; Hulihan M; Farrer MJ
Neurosci Lett; 2004 Aug; 367(1):97-100. PubMed ID: 15308306
[TBL] [Abstract][Full Text] [Related]
4. alpha-Synuclein gene and Parkinson's disease. The French Parkinson's Disease Study Group.
Science; 1998 Feb; 279(5354):1116-7. PubMed ID: 9508681
[No Abstract] [Full Text] [Related]
5. Multiple regions of alpha-synuclein are associated with Parkinson's disease.
Mueller JC; Fuchs J; Hofer A; Zimprich A; Lichtner P; Illig T; Berg D; Wüllner U; Meitinger T; Gasser T
Ann Neurol; 2005 Apr; 57(4):535-41. PubMed ID: 15786467
[TBL] [Abstract][Full Text] [Related]
6. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.
Zarranz JJ; Alegre J; Gómez-Esteban JC; Lezcano E; Ros R; Ampuero I; Vidal L; Hoenicka J; Rodriguez O; Atarés B; Llorens V; Gomez Tortosa E; del Ser T; Muñoz DG; de Yebenes JG
Ann Neurol; 2004 Feb; 55(2):164-73. PubMed ID: 14755719
[TBL] [Abstract][Full Text] [Related]
7. Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation.
Kotzbauer PT; Giasson BI; Kravitz AV; Golbe LI; Mark MH; Trojanowski JQ; Lee VM
Exp Neurol; 2004 Jun; 187(2):279-88. PubMed ID: 15144854
[TBL] [Abstract][Full Text] [Related]
8. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
[TBL] [Abstract][Full Text] [Related]
9. alpha-Synuclein promoter confers susceptibility to Parkinson's disease.
Pals P; Lincoln S; Manning J; Heckman M; Skipper L; Hulihan M; Van den Broeck M; De Pooter T; Cras P; Crook J; Van Broeckhoven C; Farrer MJ
Ann Neurol; 2004 Oct; 56(4):591-5. PubMed ID: 15455394
[TBL] [Abstract][Full Text] [Related]
10. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
Iwatsubo T
Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
[TBL] [Abstract][Full Text] [Related]
12. A Drosophila model of Parkinson's disease.
Feany MB; Bender WW
Nature; 2000 Mar; 404(6776):394-8. PubMed ID: 10746727
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease is not associated with the combined alpha-synuclein/apolipoprotein E susceptibility genotype.
Khan N; Graham E; Dixon P; Morris C; Mander A; Clayton D; Vaughan J; Quinn N; Lees A; Daniel S; Wood N; de Silva R
Ann Neurol; 2001 May; 49(5):665-8. PubMed ID: 11357958
[TBL] [Abstract][Full Text] [Related]
14. [alpha-Synuclein and familial Parkinson's disease].
Iwatsubo T
No To Shinkei; 1999 Jun; 51(6):481-6. PubMed ID: 10423749
[No Abstract] [Full Text] [Related]
15. Heredity in Parkinson's disease: new findings.
Lev N; Melamed E
Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
[TBL] [Abstract][Full Text] [Related]
16. Nosology of Parkinson's disease: looking for the way out of a quagmire.
Forman MS; Lee VM; Trojanowski JQ
Neuron; 2005 Aug; 47(4):479-82. PubMed ID: 16102530
[TBL] [Abstract][Full Text] [Related]
17. Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein.
Choi W; Zibaee S; Jakes R; Serpell LC; Davletov B; Crowther RA; Goedert M
FEBS Lett; 2004 Oct; 576(3):363-8. PubMed ID: 15498564
[TBL] [Abstract][Full Text] [Related]
18. Gene dosage and pathogenesis of Parkinson's disease.
Eriksen JL; Przedborski S; Petrucelli L
Trends Mol Med; 2005 Mar; 11(3):91-6. PubMed ID: 15760766
[TBL] [Abstract][Full Text] [Related]
19. Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease.
Mellick GD; Maraganore DM; Silburn PA
Neurosci Lett; 2005 Feb; 375(2):112-6. PubMed ID: 15670652
[TBL] [Abstract][Full Text] [Related]
20. [Study on exons 3 and 4 of alpha-synuclein gene in Chinese familial Parkinson disease patients].
Chen X; Liu YT; Li JR; Chen L; Xu YM; Pan YH; Meng XH; Xing SH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):536-8. PubMed ID: 14669226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
